Edition:
United States

NeuroMetrix Inc (NURO.OQ)

NURO.OQ on NASDAQ Stock Exchange Capital Market

2.02USD
22 Sep 2017
Change (% chg)

$-0.02 (-0.98%)
Prev Close
$2.04
Open
$2.06
Day's High
$2.06
Day's Low
$2.02
Volume
538
Avg. Vol
17,637
52-wk High
$13.28
52-wk Low
$1.71

Chart for

About

NeuroMetrix, Inc. is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. The Company is engaged in the sale of medical equipment, and consumables and accessories. It has two principal product lines: Wearable neuro-stimulatio... (more)

Overall

Beta: 0.39
Market Cap(Mil.): $4.28
Shares Outstanding(Mil.): 2.13
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.51 16.34
EPS (TTM): -- -- --
ROI: -- 13.78 14.66
ROE: -- 16.61 14.00

BRIEF-NeuroMetrix files for resale of up to 2.7 mln shares of its stock‍​

* NeuroMetrix files for resale of up to 2.7 million shares of co's common stock issuable upon conversion of shares of series F preferred stock - sec filing‍​ Source text: (http://bit.ly/2un1wUY) Further company coverage:

Aug 08 2017

BRIEF-Neurometrix announces DPNCheck distribution agreement with Fukuda Denshi in Japan

* Neurometrix announces DPNCheck distribution agreement with Fukuda Denshi in Japan Source text for Eikon: Further company coverage:

Aug 03 2017

BRIEF-NeuroMetrix reports Q2 2017 financial results

* NeuroMetrix Inc - loss from operations was $3.4 million in Q2 2017 versus $4.2 million in Q2 2016 Source text for Eikon: Further company coverage:

Jul 20 2017

BRIEF-Neurometrix announces $7.0 mln private placement of preferred stock

* Neurometrix announces $7.0 million private placement of preferred stock

Jul 10 2017

BRIEF-Curro Holdings says Stadio buys AFDA

* Stadio, has acquired 100 pct of issued share capital of The South African School Of Motion Picture Medium And Live Performance Proprietary Limited (AFDA)

Jun 08 2017

BRIEF-NEUROMETRIX ANNOUNCES ISSUANCE OF NEW U.S. PATENT FOR QUELL WEARABLE PAIN RELIEF TECHNOLOGY

* NEUROMETRIX ANNOUNCES ISSUANCE OF NEW U.S. PATENT FOR QUELL WEARABLE PAIN RELIEF TECHNOLOGY Source text for Eikon: Further company coverage:

May 22 2017

BRIEF-NeuroMetrix announces one-for-eight reverse stock split

* Announced a one-for-eight reverse split of its common stock effective as of Thursday, May 11, 2017

May 11 2017

BRIEF-NeuroMetrix announces allowance for patents for Quell Wearable Pain Relief Technology features

* Notices of Allowance issued for patents covering key features of Quell Wearable Pain Relief Technology by European Patent Office

May 08 2017

BRIEF-NeuroMetrix Q1 loss per share $0.91

* Q1 loss per share $0.91 Source text for Eikon: Further company coverage:

Apr 20 2017

Competitors

  Price Chg
Natus Medical Inc (BABY.OQ) $35.35 +0.80

Earnings vs. Estimates